Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-07-15

Clinical Trial Update: Clinical Outcomes of Persistent Atrial Fibrillation Ablation Using Ablation Index-guided Radiofrequency Catheter Ablation in Patients With Continuous Monitoring

View source ↗

Summary

A clinical trial evaluating ablation index-guided radiofrequency catheter ablation for persistent atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Louis University | Conditions: Persistent Atrial Fibrillation | Status: WITHDRAWN